Reported 2 days ago
CVS Health reported better-than-expected second quarter earnings, with revenues of $98.9 billion and adjusted earnings per share of $1.81, leading to a stock increase of over 7% in premarket trading. This marks the second consecutive quarter of growth following a challenging 2024, and the company has slightly raised its guidance for 2025. Despite facing industry-wide pressures, CVS is focused on margin recovery and investing in technology to enhance care quality as it adapts to an aging population.
Source: YAHOO